Insmed's Series C Round

Insmed raised a round of funding on July 01, 1999.

Insmed is a biopharmaceutical company dedicated to improving the lives of patients battling serious rare diseases. Insmed is focused on the development and commercialization of ARIKAYCE, or liposomal …

Articles about Insmed's Series C Round: